skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention

Review

(2188) Views  (753) Full article downloads

Authors: Shailja V Parikh, Ellen C Keeley

Published Date August 2009 Volume 2009:5 Pages 677 - 691
DOI: http://dx.doi.org/10.2147/VHRM.S4828

Shailja V Parikh1, Ellen C Keeley2

1Departments of Internal Medicine, Divisions of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, 2University of Virginia, Charlottesville, Virginia, USA

Abstract: The wide variety of anticoagulant and antiplatelet agents available for clinical use has made choosing the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention a complex task. While there is no single best regimen, from a risk-benefit ratio standpoint, particular regimens may be considered optimal for different patients. We review the mechanisms of action for the commonly prescribed antithrombotic medications, summarize pertinent data from randomized trials on their use in acute coronary syndromes, and provide an algorithm (incorporating data from these trials as well as risk assessment instruments) that will help guide the decision-making process.

Keywords: anticoagulant, antiplatelet, percutaneous coronary intervention








Readers of this article also read:
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University